Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma.
Evalyn E A P MulderJ T DwarkasingD TempelA van der SpekL BosmanD VerverA L MooyaartA A M van der VeldtC VerhoefTamar E C NijstenD J GrunhagenLoes M HollesteinPublished in: The British journal of dermatology (2020)
The CP-GEP model is a noninvasive and validated tool that accurately identified patients with primary cutaneous melanoma at low risk for nodal metastasis. In this validation cohort, the CP-GEP model has shown the potential to reduce SLNB procedures in patients with melanoma.